297 related articles for article (PubMed ID: 32362229)
1. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.
Soliman EZ; Rahman AF; Zhang ZM; Rodriguez CJ; Chang TI; Bates JT; Ghazi L; Blackshear JL; Chonchol M; Fine LJ; Ambrosius WT; Lewis CE
Hypertension; 2020 Jun; 75(6):1491-1496. PubMed ID: 32362229
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
[TBL] [Abstract][Full Text] [Related]
4. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
5. Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial.
Wang J; Jiang C; Li S; Wang Z; Wang Y; Lai Y; Wang Z; Lv W; Bai Y; Yang Z; Guo Q; Huang L; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Long D; Du X; Sang C; Dong J; Ma C
Hypertension; 2023 Nov; 80(11):2306-2314. PubMed ID: 37589154
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial.
Jiang C; Lai Y; Du X; Wang Y; Li S; He L; Hu R; Lv Q; Wu J; Feng L; Ning M; Ruan Y; Li X; Jia C; Dai W; Guo X; Jiang C; Tang R; Sang C; Long D; Arima H; Dong J; Anderson CS; Ma C
Europace; 2022 Oct; 24(10):1560-1568. PubMed ID: 35640916
[TBL] [Abstract][Full Text] [Related]
7. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
Okin PM; Hille DA; Larstorp AC; Wachtell K; Kjeldsen SE; Dahlöf B; Devereux RB
Hypertension; 2015 Aug; 66(2):368-73. PubMed ID: 26056336
[TBL] [Abstract][Full Text] [Related]
8. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
9. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.
Chen LY; Bigger JT; Hickey KT; Chen H; Lopez-Jimenez C; Banerji MA; Evans G; Fleg JL; Papademetriou V; Thomas A; Woo V; Seaquist ER; Soliman EZ
Am J Hypertens; 2016 Nov; 29(11):1276-1282. PubMed ID: 26476086
[TBL] [Abstract][Full Text] [Related]
10. Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial).
Chang TI; Reboussin DM; Chertow GM; Cheung AK; Cushman WC; Kostis WJ; Parati G; Raj D; Riessen E; Shapiro B; Stergiou GS; Townsend RR; Tsioufis K; Whelton PK; Whittle J; Wright JT; Papademetriou V;
Hypertension; 2017 Oct; 70(4):751-758. PubMed ID: 28760939
[TBL] [Abstract][Full Text] [Related]
11. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
[TBL] [Abstract][Full Text] [Related]
12. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R; Lewis CE; Lewis JB; Lash JP; Katz LA; Hawfield AT; Haley WE; Freedman BI; Dwyer JP; Drawz PE; Dobre M; Cheung AK; Campbell RC; Bhatt U; Beddhu S; Kimmel PL; Reboussin DM; Chertow GM;
Am J Kidney Dis; 2018 Mar; 71(3):352-361. PubMed ID: 29162340
[TBL] [Abstract][Full Text] [Related]
13. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
14. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
Parkash R; Wells GA; Sapp JL; Healey JS; Tardif JC; Greiss I; Rivard L; Roux JF; Gula L; Nault I; Novak P; Birnie D; Ha A; Wilton SB; Mangat I; Gray C; Gardner M; Tang ASL
Circulation; 2017 May; 135(19):1788-1798. PubMed ID: 28228428
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
[TBL] [Abstract][Full Text] [Related]
16. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
Proietti M; Romiti GF; Olshansky B; Lip GYH
Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
[TBL] [Abstract][Full Text] [Related]
17. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
[TBL] [Abstract][Full Text] [Related]
18. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.
Soliman EZ; Byington RP; Bigger JT; Evans G; Okin PM; Goff DC; Chen H
Hypertension; 2015 Dec; 66(6):1123-9. PubMed ID: 26459421
[TBL] [Abstract][Full Text] [Related]
19. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.
Odden MC; Peralta CA; Berlowitz DR; Johnson KC; Whittle J; Kitzman DW; Beddhu S; Nord JW; Papademetriou V; Williamson JD; Pajewski NM;
JAMA Intern Med; 2017 Apr; 177(4):500-507. PubMed ID: 28166324
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Blood Pressure and Body Mass Index With Risk of Incident Atrial Fibrillation in a Japanese Urban Cohort: The Suita Study.
Kokubo Y; Watanabe M; Higashiyama A; Nakao YM; Kobayashi T; Watanabe T; Okamura T; Okayama A; Miyamoto Y
Am J Hypertens; 2015 Nov; 28(11):1355-61. PubMed ID: 25845964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
